Open-label Study of Surufatinib in Japanese Patients

Clinical trial NCT05077384 · COMPLETED

Trial details

NCT number: NCT05077384
Sponsor: Hutchmed
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Neuroendocrine Tumors Non-hematologic Malignancy

Start date: 2021-09-02
Primary completion: 2024-09-06
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.